These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 15144672)

  • 1. [Overcoming multi-drug resistance using anti-MDR1 ribozymes].
    Wang H; Chen XP; Qiu FZ
    Zhonghua Wai Ke Za Zhi; 2004 Apr; 42(7):424-7. PubMed ID: 15144672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overcoming multi-drug resistance by anti-MDR1 ribozyme.
    Wang H; Chen XP; Qiu FZ
    World J Gastroenterol; 2003 Jul; 9(7):1444-9. PubMed ID: 12854138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of HCC drug resistance by using hammerhead ribozymes against multidrug resistance 1 gene.
    Qia S; Wang H; Chen X
    J Huazhong Univ Sci Technolog Med Sci; 2005; 25(6):662-4. PubMed ID: 16696319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel approaches to reversing anti-cancer drug resistance using gene-specific therapeutics.
    Kobayashi H; Takemura Y; Miyachi H
    Hum Cell; 2001 Sep; 14(3):172-84. PubMed ID: 11774737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrovirus-mediated transfer of anti-MDR1 hammerhead ribozymes into multidrug-resistant human leukemia cells: screening for effective target sites.
    Kobayashi H; Takemura Y; Wang FS; Oka T; Ohnuma T
    Int J Cancer; 1999 Jun; 81(6):944-50. PubMed ID: 10362143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrovirus-mediated transfer of anti-MDR1 ribozymes fully restores chemosensitivity of P-glycoprotein-expressing human lymphoma cells.
    Wang FS; Kobayashi H; Liang KW; Holland JF; Ohnuma T
    Hum Gene Ther; 1999 May; 10(7):1185-95. PubMed ID: 10340550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of hepatocellular carcinoma multidrug resistant monoclone cell line HepG2/mdr1.
    Chen YB; Yan ML; Gong JP; Xia RP; Liu LX; Li N; Lu SC; Zhang JG; Zeng DB; Xie JG; Yang JY; Yan LN
    Chin Med J (Engl); 2007 Apr; 120(8):703-7. PubMed ID: 17517188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Adenovirus-mediated transfer of anti-MDR1 ribozyme in the treatment of multidrug-resistant human lymphoma in SCID mice].
    Xu D; Wang F; Ohnuma T; Jin L
    Zhonghua Zhong Liu Za Zhi; 2002 Nov; 24(6):529-32. PubMed ID: 12667317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Reversal of multidrug resistance of tumor cells by anti-mdr1 ribozyme].
    Gao P; Zhou GY; Zhang QH; Zhou CJ; Zhen JH; Sun YL
    Zhonghua Bing Li Xue Za Zhi; 2004 Jun; 33(3):251-4. PubMed ID: 15256119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient long-term coexpression of a hammerhead ribozyme targeted to the U5 region of HIV-1 LTR by linkage to the multidrug-resistance gene.
    Lee CG; Jeang KT; Martin MA; Pastan I; Gottesman MM
    Antisense Nucleic Acid Drug Dev; 1997 Oct; 7(5):511-22. PubMed ID: 9361910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overcoming the classical multidrug resistance phenotype by adenoviral delivery of anti-MDR1 short hairpin RNAs and ribozymes.
    Kaszubiak A; Holm PS; Lage H
    Int J Oncol; 2007 Aug; 31(2):419-30. PubMed ID: 17611700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of drug resistance using hammerhead ribozymes against multidrug resistance-associated protein and multidrug resistance 1 gene.
    Nagata J; Kijima H; Hatanaka H; Asai S; Miyachi H; Abe Y; Yamazaki H; Nakamura M; Watanabe N; Mine T; Kondo T; Scanlon KJ; Ueyama Y
    Int J Oncol; 2002 Nov; 21(5):1021-6. PubMed ID: 12370750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Reversal of multidrug resistance by MDR1 shRNA expression vector in human leukemia K562/A02 cells].
    Xiao XB; Xie ZX; Qin Q
    Zhonghua Zhong Liu Za Zhi; 2006 Jun; 28(6):422-5. PubMed ID: 17152486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Synthesis of chimeric anti-MDR1 ribozymes (tRNA-Rzs) and their biological activities in cell-free system].
    Wang F; Lei Z; Jin L
    Zhonghua Zhong Liu Za Zhi; 2000 May; 22(3):184-8. PubMed ID: 11778226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversion of multidrug resistance in the P-glycoprotein positive breast cancer cell line (MCF-7/ADR) by introduction of hammerhead ribozyme.
    Yuan Y; Zhang J; Scanlon KJ; Lu Z; Qi G
    Chin Med Sci J; 1998 Mar; 13(1):24-8. PubMed ID: 11717919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of multidrug resistance by a liposome-MDR1 ribozyme complex.
    Masuda Y; Kobayashi H; Holland JF; Ohnuma T
    Cancer Chemother Pharmacol; 1998; 42(1):9-16. PubMed ID: 9619752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Quantitative analysis of multidrug resistance phenotype in hematological malignancies].
    Kobayashi H; Takemura Y
    Rinsho Byori; 1998 Apr; 46(4):380-90. PubMed ID: 9594630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of drug resistance of hepatocellular carcinoma cells by adenoviral delivery of anti-MDR1 ribozymes.
    Huesker M; Folmer Y; Schneider M; Fulda C; Blum HE; Hafkemeyer P
    Hepatology; 2002 Oct; 36(4 Pt 1):874-84. PubMed ID: 12297834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restoration of chemosensitivity in cancer cells with MDR phenotype by deoxyribozyme, compared with ribozyme.
    Xing AY; Shi DB; Liu W; Chen X; Sun YL; Wang X; Zhang JP; Gao P
    Exp Mol Pathol; 2013 Jun; 94(3):481-5. PubMed ID: 23531420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal MDR in breast carcinoma cells by transfection of ribozyme designed according the secondary structure of mdr1 mRNA.
    Gao P; Zhou GY; Zhang QH; Li H; Mu K; Yuan YP; Zhang J; Wang BH
    Chin J Physiol; 2006 Apr; 49(2):96-103. PubMed ID: 16830791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.